1-((1-(3-(2-allylphenoxy)-2-hydroxypropyl)piperidin-4-yl)methyl)piperidine-2,6-dione

ID: ALA1085009

PubChem CID: 46889767

Max Phase: Preclinical

Molecular Formula: C23H32N2O4

Molecular Weight: 400.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CCc1ccccc1OCC(O)CN1CCC(CN2C(=O)CCCC2=O)CC1

Standard InChI:  InChI=1S/C23H32N2O4/c1-2-6-19-7-3-4-8-21(19)29-17-20(26)16-24-13-11-18(12-14-24)15-25-22(27)9-5-10-23(25)28/h2-4,7-8,18,20,26H,1,5-6,9-17H2

Standard InChI Key:  YLVVPHSFBDIKPJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -3.0044   -2.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2880   -1.8102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2909   -0.9797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5779   -0.5645    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8619   -0.9743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1490   -0.5591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5670   -0.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1521    0.2659    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2799   -0.5537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9958   -0.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7066   -0.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7078    0.2704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9919    0.6824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2749    0.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4222    0.6828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1367    0.2703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1310   -0.5596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8454    0.6799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8429   -0.9686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5603    0.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5558   -0.5607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4156   -0.9705    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8470    1.5049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7193   -1.8107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7226   -0.9818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0104   -0.5681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0131    0.2569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3000    0.6718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3027    1.4968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
 13 14  1  0
  2  3  1  0
 12 15  1  0
  6  7  1  0
 15 16  1  0
 16 17  1  0
  3 26  2  0
  6  8  1  0
 16 18  1  0
 17 19  1  0
 20 18  1  0
 21 19  1  0
  7  9  1  0
  9 10  1  0
 20 21  1  0
  3  4  1  0
 17 22  2  0
  1  2  2  0
 18 23  2  0
 24 25  2  0
  4  5  1  0
 25 26  1  0
 24  1  1  0
  5  6  1  0
  9 14  1  0
 26 27  1  0
 10 11  1  0
 27 28  1  0
 11 12  1  0
 28 29  2  0
M  END

Associated Targets(Human)

ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 400.52Molecular Weight (Monoisotopic): 400.2362AlogP: 2.41#Rotatable Bonds: 9
Polar Surface Area: 70.08Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.54CX LogP: 2.27CX LogD: 1.10
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -0.73

References

1. Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P..  (2010)  A vHTS approach for the identification of beta-adrenoceptor ligands.,  20  (11): [PMID:20434333] [10.1016/j.bmcl.2010.04.009]

Source